Production of multilineage growth factors by hematopoietic stromal cells: An intercellular regulatory network involving mononuclear phagocytes and interleukin-1

    Research output: Contribution to journalArticle

    29 Citations (Scopus)

    Abstract

    In the past 8 years, our group has carried out a series of in-vitro studies designed to characterize the role of mononuclear phagocytes as regulators of human hematopoiesis. The results of this program of investigation, some of which are reviewed below, led to the discovery that mononuclear phagocytes are more efficient recruitors of growth factor release by other cells than they are direct stimulators of progenitor cell growth. Specifically, mononuclear phagocytes release soluble factors (MRA) that stimulate other cells, including vascular endothelial cells, skin fibroblasts, and marrow fibroblasts, to release multilineage hematopoietic growth factors. Experiments designed to purify and characterize these monokines indicated unambiguously that the MRA that stimulates granulocyte/macrophage colony stimulating factor (GM-CSF) release is interleukin-1 (IL-1). Based on these observations and recent observations by other groups on the hematopoietic effects of other monokines including tumor necrosis factor alpha, we argue that mononuclear phagocytes serve as important regulators of hematopoiesis by producing monokines that, in turn, induce the expression of multiple hematopoietic growth factor genes in stromal cells of the hematopoietic microenvironment. Because IL-1 molecules and the mononuclear phagocytes producing them are evolutionarily conserved, and in view of the heterogeneous nonhematopoietic effects of these monokines, studies on their role in hematopoiesis may also provide new understanding of the molecular evolution of multicellular organisms.

    Original languageEnglish (US)
    Pages (from-to)147-159
    Number of pages13
    JournalBlood Cells
    Volume13
    Issue number1-2
    StatePublished - 1987

    Fingerprint

    Monokines
    Phagocytes
    Stromal Cells
    Interleukin-1
    Intercellular Signaling Peptides and Proteins
    Hematopoiesis
    Fibroblasts
    Cellular Microenvironment
    Molecular Evolution
    Granulocyte-Macrophage Colony-Stimulating Factor
    Stem Cells
    Endothelial Cells
    Tumor Necrosis Factor-alpha
    Bone Marrow
    Skin
    Growth
    Genes

    ASJC Scopus subject areas

    • Hematology

    Cite this

    @article{91c0e09aabb64575b2c2aad0f7139078,
    title = "Production of multilineage growth factors by hematopoietic stromal cells: An intercellular regulatory network involving mononuclear phagocytes and interleukin-1",
    abstract = "In the past 8 years, our group has carried out a series of in-vitro studies designed to characterize the role of mononuclear phagocytes as regulators of human hematopoiesis. The results of this program of investigation, some of which are reviewed below, led to the discovery that mononuclear phagocytes are more efficient recruitors of growth factor release by other cells than they are direct stimulators of progenitor cell growth. Specifically, mononuclear phagocytes release soluble factors (MRA) that stimulate other cells, including vascular endothelial cells, skin fibroblasts, and marrow fibroblasts, to release multilineage hematopoietic growth factors. Experiments designed to purify and characterize these monokines indicated unambiguously that the MRA that stimulates granulocyte/macrophage colony stimulating factor (GM-CSF) release is interleukin-1 (IL-1). Based on these observations and recent observations by other groups on the hematopoietic effects of other monokines including tumor necrosis factor alpha, we argue that mononuclear phagocytes serve as important regulators of hematopoiesis by producing monokines that, in turn, induce the expression of multiple hematopoietic growth factor genes in stromal cells of the hematopoietic microenvironment. Because IL-1 molecules and the mononuclear phagocytes producing them are evolutionarily conserved, and in view of the heterogeneous nonhematopoietic effects of these monokines, studies on their role in hematopoiesis may also provide new understanding of the molecular evolution of multicellular organisms.",
    author = "Bagby, {G. C.}",
    year = "1987",
    language = "English (US)",
    volume = "13",
    pages = "147--159",
    journal = "Blood Cells, Molecules, and Diseases",
    issn = "1079-9796",
    publisher = "Academic Press Inc.",
    number = "1-2",

    }

    TY - JOUR

    T1 - Production of multilineage growth factors by hematopoietic stromal cells

    T2 - An intercellular regulatory network involving mononuclear phagocytes and interleukin-1

    AU - Bagby, G. C.

    PY - 1987

    Y1 - 1987

    N2 - In the past 8 years, our group has carried out a series of in-vitro studies designed to characterize the role of mononuclear phagocytes as regulators of human hematopoiesis. The results of this program of investigation, some of which are reviewed below, led to the discovery that mononuclear phagocytes are more efficient recruitors of growth factor release by other cells than they are direct stimulators of progenitor cell growth. Specifically, mononuclear phagocytes release soluble factors (MRA) that stimulate other cells, including vascular endothelial cells, skin fibroblasts, and marrow fibroblasts, to release multilineage hematopoietic growth factors. Experiments designed to purify and characterize these monokines indicated unambiguously that the MRA that stimulates granulocyte/macrophage colony stimulating factor (GM-CSF) release is interleukin-1 (IL-1). Based on these observations and recent observations by other groups on the hematopoietic effects of other monokines including tumor necrosis factor alpha, we argue that mononuclear phagocytes serve as important regulators of hematopoiesis by producing monokines that, in turn, induce the expression of multiple hematopoietic growth factor genes in stromal cells of the hematopoietic microenvironment. Because IL-1 molecules and the mononuclear phagocytes producing them are evolutionarily conserved, and in view of the heterogeneous nonhematopoietic effects of these monokines, studies on their role in hematopoiesis may also provide new understanding of the molecular evolution of multicellular organisms.

    AB - In the past 8 years, our group has carried out a series of in-vitro studies designed to characterize the role of mononuclear phagocytes as regulators of human hematopoiesis. The results of this program of investigation, some of which are reviewed below, led to the discovery that mononuclear phagocytes are more efficient recruitors of growth factor release by other cells than they are direct stimulators of progenitor cell growth. Specifically, mononuclear phagocytes release soluble factors (MRA) that stimulate other cells, including vascular endothelial cells, skin fibroblasts, and marrow fibroblasts, to release multilineage hematopoietic growth factors. Experiments designed to purify and characterize these monokines indicated unambiguously that the MRA that stimulates granulocyte/macrophage colony stimulating factor (GM-CSF) release is interleukin-1 (IL-1). Based on these observations and recent observations by other groups on the hematopoietic effects of other monokines including tumor necrosis factor alpha, we argue that mononuclear phagocytes serve as important regulators of hematopoiesis by producing monokines that, in turn, induce the expression of multiple hematopoietic growth factor genes in stromal cells of the hematopoietic microenvironment. Because IL-1 molecules and the mononuclear phagocytes producing them are evolutionarily conserved, and in view of the heterogeneous nonhematopoietic effects of these monokines, studies on their role in hematopoiesis may also provide new understanding of the molecular evolution of multicellular organisms.

    UR - http://www.scopus.com/inward/record.url?scp=0023269048&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0023269048&partnerID=8YFLogxK

    M3 - Article

    C2 - 3311215

    AN - SCOPUS:0023269048

    VL - 13

    SP - 147

    EP - 159

    JO - Blood Cells, Molecules, and Diseases

    JF - Blood Cells, Molecules, and Diseases

    SN - 1079-9796

    IS - 1-2

    ER -